Prescient Therapeutics Ltd
ASX:PTX
Prescient Therapeutics Ltd
Cash from Investing Activities
Prescient Therapeutics Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prescient Therapeutics Ltd
ASX:PTX
|
Cash from Investing Activities
AU$4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immutep Ltd
ASX:IMM
|
Cash from Investing Activities
-AU$82.7k
|
CAGR 3-Years
-109%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Investing Activities
-$45k
|
CAGR 3-Years
75%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Cash from Investing Activities
-$1.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Investing Activities
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
40%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Investing Activities
-AU$25.5m
|
CAGR 3-Years
-186%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
See Also
What is Prescient Therapeutics Ltd's Cash from Investing Activities?
Cash from Investing Activities
4m
AUD
Based on the financial report for Dec 31, 2023, Prescient Therapeutics Ltd's Cash from Investing Activities amounts to 4m AUD.